Home > Healthcare > Drug Device Combination > Therapeutic Systems > Amniotic Membrane Market
Amniotic Membrane Market size was valued at around USD 1.6 billion in 2023 and is anticipated to register a CAGR of over 11.2% between 2024 and 2032. The amniotic membrane is a thin, transparent layer of tissue that surrounds and protects the developing embryo or fetus during pregnancy. It forms part of the amniotic sac, which is a fluid-filled sac that encases the developing fetus within the uterus.
Amniotic membrane has become a valuable resource in wound care, an industry valued at USD 21.2 billion in 2022, particularly for chronic wounds such as diabetic foot ulcers and pressure ulcers. Furthermore, in the U.S. alone, approximately two million individuals annually develop diabetic foot ulcers, with over 50% facing mortality and 5% enduring limb amputation within a five-year period following ulceration. The amniotic membrane's regenerative properties have led to a growing emphasis on its use in regenerative medicine. The market has seen increased interest in utilizing amniotic membrane products for tissue repair and regeneration in various medical applications.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Amniotic Membrane Market Size in 2023: | USD 1.6 Billion |
Forecast Period: | 2024 – 2032 |
Forecast Period 2024 – 2032 CAGR: | 11.2% |
2024 – 2032 Value Projection: | USD 4.1 Billion |
Historical Data for: | 2018 – 2023 |
No. of Pages: | 163 |
Tables, Charts & Figures: | 201 |
Segments covered: | Product, Application, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|